Application of lipid nanovesicle drug delivery system in cancer immunotherapy

Immunotherapy has gradually emerged as the most promising anticancer therapy. In addition to conventional anti-PD-1/PD-L1 therapy, anti-CTLA-4 therapy, CAR-T therapy, etc., immunotherapy can also be induced by stimulating the maturation of immune cells or inhibiting negative immune cells, regulating...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Yinan, Wang, Luhong, Li, Han, Miao, Fengqin, Zhang, Zhiyuan, Hu, Chunmei, Yu, Weiping, Tang, Qiusha, Shao, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073823/
https://www.ncbi.nlm.nih.gov/pubmed/35524277
http://dx.doi.org/10.1186/s12951-022-01429-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9073823/
https://www.ncbi.nlm.nih.gov/pubmed/35524277
http://dx.doi.org/10.1186/s12951-022-01429-2

Ejemplares similares